Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

Cancer Research Center of Toulouse at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Cancer Research Center of Toulouse brings 1 presentation to ASH 2026 in New Orleans. Its program centres on why acute myeloid leukemia resists chemotherapy. It covers the biology of the leukemia cells that survive treatment.

OrganizationASH 2026 Attendance
crct-inserm.fr
Universities & research institutes
Cancer research institute in Toulouse, France, run by Inserm, CNRS and the University of Toulouse.
Talk
Part of Scientific Program: Innovations in the Detection and Characterization of Chemoresistant Cells in AML: From Molecular MRD to Molecular Resistance Mechanisms
Biological Insights into Resistant Cells
Leukemia cells that survive treatment and seed relapse lean on mitochondrial energy production, and their metabolic and surface features could be drug targets.
Leukemias
Talk

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Cancer Research Center of Toulouse

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction